This week, the U.S. Preventive Services Task Force is set to issue a draft recommendation against the use of prostate-specific antigen blood screening for all healthy men. "Unfortunately, the evidence now shows that this test does not save men's lives," said Dr. Virginia Moyer, the task force chairwoman. "This test cannot tell the difference between cancers that will and will not affect a man during his natural lifetime. We need to find one that does."
Published in Brief: